April Proefrock

Phase I clinical trial of recombinant human tumor necrosis factor

PatrickJ. Creaven, JohnE. Plager, S Dupéré et al. · Cancer Chemotherapy and Pharmacology · 1987 · 149 citations

Life Sciences, Immunology, Oncology +9

Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer.

Steven J. Cohen, Cynthia G. Leichman, Gwen Yeslow et al. · PubMed · 2002 · 46 citations

Pharmacy, Oncology, Pharmacology +17

Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation

Sameer Gupta, Nikolaos G. Almyroudis, Minoo Battiwalla et al. · Transplant Infectious Disease · 2007 · 26 citations

Medicine, Hematology, Pharmacology +16

Phase I and pharmacokinetic evaluation of floxuridine/leucovorin given on the Roswell Park weekly regimen

Patrick J. Creaven, Youcef M. Rustum, Nicholas J. Petrelli et al. · Cancer Chemotherapy and Pharmacology · 1994 · 13 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Initial clinical trial and pharmacokinetics of Thymitaq TM (AG337) by 10-day continuous infusion in patients with advanced solid tumors

Patrick J. Creaven, Lakshmi Pendyala, Neal J. Meropol et al. · Cancer Chemotherapy and Pharmacology · 1997 · 11 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +7